A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.

<h4>Introduction</h4>New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarker...

Full description

Saved in:
Bibliographic Details
Main Authors: Brian W Johnston, Michael Downes, Angela Hall, Zachary Thomas, Ingeborg D Welters
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0318365
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206822653394944
author Brian W Johnston
Michael Downes
Angela Hall
Zachary Thomas
Ingeborg D Welters
author_facet Brian W Johnston
Michael Downes
Angela Hall
Zachary Thomas
Ingeborg D Welters
author_sort Brian W Johnston
collection DOAJ
description <h4>Introduction</h4>New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarkers in sepsis are thought to be associated with NOAF development. The aim of this systematic review and narrative synthesis is to identify inflammatory and coagulation biomarkers as predisposing risk factors for NOAF in sepsis.<h4>Methods</h4>Three databases (Medline, Cochrane Library, and Scopus) were searched using a predefined search strategy. Inclusion / exclusion criteria were applied, and quality assessments were performed using the Newcastle Ottawa Scale (NOS).<h4>Results</h4>We identified 1776 articles; and 12 articles were included in this review. 8 articles were retrospective observational studies and 4 were prospective observational studies. There was considerable heterogeneity between studies regarding outcomes, methodological design, quality, definitions and reported biomarkers of interest. There is evidence that C-reactive protein (CRP) is associated with NOAF, with hazard ratios 3.33 (3.32-3.35) p = 0.001 and odds ratios of 1.011 (1.008-1.014) p<0.001. International Normalised Ratio (INR) and fibrinogen may be associated with NOAF with odds ratios reported as 1.837 (1.270-2.656) p = 0.001 and 1.535(1.232-1.914) p<0.001 respectively.<h4>Conclusion</h4>Further research is required to confirm the association between inflammatory and coagulation biomarkers and the development of NOAF in sepsis. A broader evidence base will guide treatment strategies, improving the standard of care for patients who develop NOAF in sepsis. Furthermore, given the heterogeneity between studies consideration should be given to inclusion of immune biomarkers in future core outcome sets for trials investigating NOAF.
format Article
id doaj-art-c924a042350d44a39d8684888c9ce870
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-c924a042350d44a39d8684888c9ce8702025-02-07T05:30:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031836510.1371/journal.pone.0318365A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.Brian W JohnstonMichael DownesAngela HallZachary ThomasIngeborg D Welters<h4>Introduction</h4>New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarkers in sepsis are thought to be associated with NOAF development. The aim of this systematic review and narrative synthesis is to identify inflammatory and coagulation biomarkers as predisposing risk factors for NOAF in sepsis.<h4>Methods</h4>Three databases (Medline, Cochrane Library, and Scopus) were searched using a predefined search strategy. Inclusion / exclusion criteria were applied, and quality assessments were performed using the Newcastle Ottawa Scale (NOS).<h4>Results</h4>We identified 1776 articles; and 12 articles were included in this review. 8 articles were retrospective observational studies and 4 were prospective observational studies. There was considerable heterogeneity between studies regarding outcomes, methodological design, quality, definitions and reported biomarkers of interest. There is evidence that C-reactive protein (CRP) is associated with NOAF, with hazard ratios 3.33 (3.32-3.35) p = 0.001 and odds ratios of 1.011 (1.008-1.014) p<0.001. International Normalised Ratio (INR) and fibrinogen may be associated with NOAF with odds ratios reported as 1.837 (1.270-2.656) p = 0.001 and 1.535(1.232-1.914) p<0.001 respectively.<h4>Conclusion</h4>Further research is required to confirm the association between inflammatory and coagulation biomarkers and the development of NOAF in sepsis. A broader evidence base will guide treatment strategies, improving the standard of care for patients who develop NOAF in sepsis. Furthermore, given the heterogeneity between studies consideration should be given to inclusion of immune biomarkers in future core outcome sets for trials investigating NOAF.https://doi.org/10.1371/journal.pone.0318365
spellingShingle Brian W Johnston
Michael Downes
Angela Hall
Zachary Thomas
Ingeborg D Welters
A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.
PLoS ONE
title A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.
title_full A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.
title_fullStr A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.
title_full_unstemmed A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.
title_short A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis.
title_sort systematic review on the influence of coagulopathy and immune activation on new onset atrial fibrillation in patients with sepsis
url https://doi.org/10.1371/journal.pone.0318365
work_keys_str_mv AT brianwjohnston asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis
AT michaeldownes asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis
AT angelahall asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis
AT zacharythomas asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis
AT ingeborgdwelters asystematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis
AT brianwjohnston systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis
AT michaeldownes systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis
AT angelahall systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis
AT zacharythomas systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis
AT ingeborgdwelters systematicreviewontheinfluenceofcoagulopathyandimmuneactivationonnewonsetatrialfibrillationinpatientswithsepsis